Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03879681
Other study ID # Snakes UK
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 2019
Est. completion date April 2020

Study information

Verified date March 2019
Source National Health Service, United Kingdom
Contact Thomas Engelhardt, Prof
Phone (0044) 1224 550128
Email t.engelhardt@nhs.net
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Postoperative nausea and vomiting in children is a common phenomenon, particularly after ear nose and throat (ENT) surgery. While it affects up to 80% of patients who do not receive preventative medication during their operation, more than 1 in 5 children still suffer from postoperative nausea and vomiting after tonsillectomy even when given 2 medications to prevent it. Nausea and vomiting after an operation (postoperatively) particularly following tonsillectomy can be very painful and distressing for the child and their carer. Vomiting may also increase the risk of postoperative bleeding, a serious complication after the surgery. Postoperative nausea and vomiting is not only one of the main reasons for prolonged hospital stay or re-admission in children; it is also one of the main reasons for dissatisfaction with anaesthesia in children and their families. In adults, a pilot study has found that chewing gum postoperatively can significantly reduce postoperative nausea and vomiting. Chewing and swallowing, results in increased activity in the gut and lessens the effects of medications given under anaesthesia that tend to slow the gut.

However, for young children particularly following anaesthesia, chewing gum may not be a safe option. Therefore, in this pilot study the investigators will investigate if chewing a large jelly confectionary snake after the anaesthetic will help to reduce nausea and vomiting. The children who are enrolled in the study will be randomised to receive a jelly snake or no jelly snake to chew once awake after the surgery. There will be no other changes to the standard management which will be in accordance to institutional guidelines. The investigators will then compare the rates of vomiting between the children who did and did not receive a jelly snake to chew. We will also monitor other oral and food intake and requirements for painkillers, as well as for other potential problems (e.g. delayed discharge) after surgery.

The advantage of using a jelly snake is that it is a simple, inexpensive, non-drug treatment. Parents are very keen to avoid the use of drugs for their children and so would be open to the use of this new approach. For children the jelly snake offers something familiar and an enjoyable solution to their discomfort. The use of jelly snakes could also be a simple intervention that parents could do at home following day case surgery for other procedures. While the jelly snakes are high in sugar, they are comparable to the sugar content of a glass of fruit juice, flavoured milk or soft drinks. Generally, in the investigators' experience, the willingness of parents to allow their children to receive treats in the postoperative period is very high, particularly since all children have a significant time of fasting (at least 6 hours, often longer) for solid foods prior to surgery.


Description:

Primary Hypothesis Chewing large jelly snakes will significantly reduce the development of postoperative vomiting in paediatric patients in the first 6 hours after volatile anaesthetic-based general anaesthesia for tonsillectomies +/- adenoidectomies.

Secondary Hypotheses:

1. Jelly snakes will reduce the incidence of nausea in the first 6 hours after tonsillectomy +/- adenoidectomy surgery

2. Jelly snakes will reduce rescue treatments for PONV in the first 6 hours

3. Jelly snakes will reduce the incidence of PONV in the first 24 hours or up until discharge in case of tonsillectomies (whatever occurs first)

4. Jelly snakes will reduce rescue treatments for PONV in the first 24 hours or up until discharge in case of tonsillectomies (whatever occurs first)

Safety Hypotheses:

Children will be able to chew and swallow jelly snakes post-surgery. No jelly snake or parts thereof will be inhaled in those receiving treatment.

Aims This pilot study aims to investigate if chewing jelly confectionary snakes after tonsillectomies +/- adenoidectomies will significantly reduce the incidence of postoperative nausea/vomiting (PONV) in children.

Study Design One site pilot trial of the effectiveness of chewy jelly snakes in the prevention of POV involving the Royal Aberdeen Children Hospital, UK.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 240
Est. completion date April 2020
Est. primary completion date April 2020
Accepts healthy volunteers No
Gender All
Age group 2 Years to 16 Years
Eligibility Inclusion Criteria:

- Volatile anaesthetic-based general anaesthesia

- Written informed parental consent

- Elective tonsillectomy +/- adenoidectomy (+/- myringotomy, EUA ear, grommets or cautery of inferior turbinates')

Exclusion Criteria:

- Plan to use muscle relaxant

- Plan to use topical lignocaine on the vocal cords intraoperatively

- Contraindication to chewy jelly snakes or any of their components e.g. known allergy to any of the ingredients of the chewy jelly snakes or impaired pharyngeal/oesophageal function (e.g. bulbar palsy, achalasia), children with diabetes and vegetarian children

- Contraindication to any protocolised anti-emetic drug (prophylaxis, intervention or rescue)

- Parents/guardians or children who, in the opinion of the investigator, may be unable to understand or give informed consent will be excluded from the study.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Jelly confectionary Snakes
The participants will be randomized by computer generated randomisation to receive either the jelly snake (n=120) or no intervention (n=120) apart from standard institutional management. All children randomised into the snake group will be offered a chewy jelly snake once alert and cooperative in PACU or on the ward once University of Michigan Sedation Scale (UMSS) is 025,26. The UMSS is a simple observational tool that assesses the level of alertness on a five-point scale ranging from 1 (wide awake) to 5 (unarousable with deep stimulation). The children randomized into the control group will receive a chewy jelly snake as a treat at discharge.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Prof. Thomas Engelhardt

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of postoperative vomiting in paediatric patients in the first 6 hours after volatile anaesthetic-based general anaesthesia for adenoidectomies and / or tonsillectomies up to 6 hours after the end of the surgery
Secondary Incidence of nausea in the first 6 hours post tonsillectomy +/- adenoidectomy surgery in children over 8 years up to 6 hours after the surgery
Secondary • Number of rescue treatments for PONV in the first 6 hours up to 6 hours after the surgery
Secondary • Incidence of PONV in the first 24 hours or up until discharge (whatever occurs first) Up to 24 hours
Secondary • Time to first vomit if applicable (measured from arrival in PACU) Up to 24 hours
Secondary • Time to first meal Up to 24 hours
Secondary • Duration of hospital stay Up to 48 hours
See also
  Status Clinical Trial Phase
Completed NCT03266094 - A Study of BiZact™ on Children and Adolescents Undergoing Tonsillectomy N/A
Completed NCT02228135 - The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage N/A
Completed NCT00662987 - Effect of Duration of Antibiotic Therapy on Recovery Following Tonsillectomy N/A
Completed NCT00273754 - The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA). Phase 2
Recruiting NCT06122948 - Effect of Intranasal Midazolam Versus Ketamine Midazolam Combination as a Premedication on the Occurrence of Postoperative Respiratory Adverse Events Phase 3
Recruiting NCT03783182 - Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy Phase 4
Completed NCT03793816 - Tonsillectomy Using BiZact™ - a Randomized Side-controlled Clinical Trial N/A
Not yet recruiting NCT06359925 - Suprazygomatic Nerve Block in Tonsillectomy Patients N/A
Recruiting NCT06079125 - PFDD Versus PFDRT in Chiari Decompression Surgery N/A
Recruiting NCT01904461 - HemORL: Monocentric, Prospective, Comparative Study on the Use of a Haemostatic Vacuum Device During Tonsillectomy in Children N/A
Not yet recruiting NCT00756873 - Etoricoxib in Ear Nose Throat Surgery Phase 3
Recruiting NCT05600595 - The Evaluation of Eustachian Tube Function and Its Influencing Factors After Snoring Operation in Children
Completed NCT02987985 - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy Phase 3
Completed NCT04066829 - Default Dosing Settings for Opioid Prescriptions to Adolescents and Young Adults After Tonsillectomy N/A
Recruiting NCT05158348 - A Comparative Study to Measure the Effect of Nebulized Dexmedetomidine Phase 3
Completed NCT01605903 - Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy Phase 2
Enrolling by invitation NCT02444533 - EXPAREL® for Pain After Tonsillectomy Phase 4
Recruiting NCT02829515 - Tonsil Surgery in Sweden: A National Quality Register
Not yet recruiting NCT03491085 - Role of Antibiotics Post Tonsillectomy Phase 1/Phase 2
Recruiting NCT05270109 - Cold Steel Versus "Hot" BiZact Tonsillectomy; Comparing Post Tonsillectomy Morbidity N/A